FIELD: endocrinology. SUBSTANCE: after normalization of metabolism, biologically active points for introducing cellular suspension are found, which points are related to 4-6 damaged organs. Cellular suspension is prepared from mammal organs and is introduced in amounts 0.3-0.5 ml per injection, 2 to 5 injections being made for each damaged organ. EFFECT: reduced doses of administered insulin, prolonged remission terms, and stabilized diabetes mellitus course period. 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIOTRANSPLANT AND METHOD FOR TREATING THE CASES OF DIABETES MELLITUS OF TYPE I AND II | 2004 |
|
RU2265443C1 |
| METHOD FOR PRODUCING RABBIT PANCREATIC BETA CELLS AND COMPOSITION FOR STIMULATING NATURAL INSULIN DEVELOPMENT IN PATIENT | 2007 |
|
RU2450052C2 |
| CELL SUSPENSION-BASED IMMUNOCORRECTING DRUG AND USING THIS DRUG IN A METHOD OF TREATING DIABETES MELLITUS | 1994 |
|
RU2126260C1 |
| METHOD FOR TREATING DIABETIC RETINOPATHY | 1999 |
|
RU2157154C1 |
| METHOD OF TREATING DIABETIC NEPHROPATHY | 2011 |
|
RU2476251C1 |
| METHOD OF TREATMENT OF PATIENTS WITH DIABETES MELLITUS | 2000 |
|
RU2165263C1 |
| METHOD FOR PREDICTING DEGREE OF DIABETES GRAVITY IN CHILDREN AND ADOLESCENTS | 1997 |
|
RU2138053C1 |
| ELIXIR SHOWING TOTAL TONIC AND ADAPTOGENIC ACTION | 2000 |
|
RU2171113C1 |
| METHOD OF DIAGNOSIS OF OVERDOSE OF INSULIN IN CHILDREN AND ADOLESCENTS SUFFERING FROM DIABETES MELITUS | 0 |
|
SU1506356A1 |
| PHARMACEUTICAL COMPOSITION FOR BLOOD SUGAR AND FAT CONTROL, ITS MANUFACTURING AND ADMINISTRATION THEREOF | 2007 |
|
RU2409381C1 |
